FDA Clears Renovis’ Fifth Titanium Structure Implant System
Renovis Surgical has secured FDA 510(k) clearance for its 3D-printed titanium interbody fusion systems.
The system includes direct posterior or transforaminal implants of multiple widths, heights and lengths. Renovis previously received FDA clearance for four other porous titanium structure product groups.
The technology allows bones to attach to implant surfaces and have the potential for biologic fixation deep into the pore structure.